Monoclonal Antibody Therapeutics Market, By Source, by Application, By Distribution Channel, and By Region
상품코드:1789491
리서치사:Coherent Market Insights
발행일:2025년 07월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
단클론항체 치료제 시장은 2025년에는 2,939억 2,000만 달러, 2032년에는 6,783억 1,000만 달러에 이르고, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 12.69%로 성장할 것으로 예측됩니다.
보고 범위
보고서 세부정보
기준 연도
2024년
2025년 시장 규모
2,939억 2,000만 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측기간 2025-2032년 CAGR
12.69%
2032년 가치 예측
6,783억 1,000만 달러
면역 체계는 박테리아와 바이러스와 같은 질병을 일으키는 병원체를 검출하고 파괴하는 복잡한 팀으로 구성됩니다. 마찬가지로 이 시스템은 암세포와 같은 손상된 세포를 제거할 수 있습니다. 면역계가 침입자를 찾아 파괴하는 방법 중 하나는 항체입니다. 단일클론항체 요법은 특정 세포 및 단백질에 단특이적으로 결합하는 단클론항체(mAbs)를 이용한 면역요법의 일종입니다. 이 치료의 목적은 환자의 면역계를 자극하여 세포를 공격하는 것입니다. 지난 몇 년간 CTLA-4, PD-1, PD-L1 등의 면역 체크포인트에 작용하는 독자적인 작용기전을 가진 다양한 단클론항체가 승인되었습니다. 각 제조업체는 암에서 희귀질환까지 다양한 질병을 치료하기 위해 다양한 클래스에 속하는 약제의 개발에 주력하고 있습니다. 단클론항체와 화학요법제의 병용은 다양한 암을 치료하는 유력한 선택이 되고 있습니다. 또한 2020년에는 COVID-19 치료용 단클론항체 치료제의 개발이 활발해졌습니다.
시장 역학
이 시장에서는 주요 규제 당국에 의한 제품 포트폴리오 확대의 인가 등 성장 전략의 채택이 증가하고 있어 예측 기간 중 시장 성장의 원동력이 될 것으로 예측됩니다. 예를 들어, 2022년 2월, 미국 식품의약국(FDA)은 오미크론 변이체에 대한 활성을 보유하는 COVID-19 치료용 제약회사 Lilly사의 신규 단클론항체 bebtelovimab의 비상사용 인가(EUA)를 발행했습니다.
본 조사의 주요 특징
본 보고서에서는 세계의 단클론항체 치료제 시장을 상세하게 분석하여 2024년을 기준연도로 한 2025-2032년 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시와 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
세계 단클론항체 치료제 시장의 주요 기업 프로파일은 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 게시됩니다.
이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 상시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
세계 단클론항체 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 판매자, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자는 세계의 단일클론 항체 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
성장 촉진요인
억제요인
시장 기회
영향 분석
주요 하이라이트
제품 발매
기술의 진보
PEST 분석
규제 시나리오
합병과 인수
제4장 세계의 단클론항체 치료제 시장, 공급원별, 2020년-2032년
인간
키메라
쥐
Humanized
제5장 세계의 단클론항체 치료제 시장, 용도별, 2020년-2032년
암
자가면역 질환
혈액 질환
감염증
기타
제6장 세계의 단클론항체 치료제 시장, 유통 채널별, 2020년-2032년
병원 약국
소매 약국
온라인 약국
제7장 세계의 단클론항체 치료제 시장, 지역별, 2020년-2032년
북미
미국
캐나다
라틴아메리카
브라질
멕시코
아르헨티나
기타 라틴아메리카
유럽
영국
독일
이탈리아
프랑스
스페인
러시아
기타 유럽
아시아태평양
중국
인도
일본
ASEAN
호주
한국
기타 아시아태평양
중동
GCC
이스라엘
기타 중동
아프리카
북아프리카
중앙 아프리카
남아프리카
제8장 경쟁 구도
Pfizer Inc.
Novartis AG
Bayer AG
Sanofi
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Merck KGaA
GSK plc
AbbVie Inc.
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals Inc.
AstraZeneca
AbCellera Biologics Inc.
Molecular Depot LLC
DAIICHI SANKYO COMPANY, LIMITED
Abbott
Biogen
Thermo Fisher Scientific, Inc.
Cell Signaling Technology, Inc.
Intas Pharmaceuticals Ltd.
Avantor, Inc.
UCB SA
Merus NV
GENEXTGENOMICS.COM
Biogenuix
제9장 섹션
조사 방법
출판사에 대해
SHW
영문 목차
영문목차
Monoclonal Antibody Therapeutics Market is estimated to be valued at USD 293.92 Bn in 2025 and is expected to reach USD 678.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.69% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 293.92 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
12.69%
2032 Value Projection:
USD 678.31 Bn
The immune system is made up of a complex team of players that detect and destroy disease-causing agents, such as bacteria and viruses. Similarly, this system may eliminate damaged cells, such as cancer cells. One way the immune system finds and destroys invaders is with antibodies. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAbs) to bind monospecifically to certain cells or proteins. The objective is that this treatment will stimulate the patient's immune system to attack those cells. Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. Also, there was a boost in the development of monoclonal antibody therapeutics for the treatment of COVID-19 in the year 2020
Market Dynamics
Increasing adoption of growth strategies, such as authorization by key regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in February 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a new monoclonal antibody, bebtelovimab manufactured by Lilly, a pharmaceutical company for the treatment of COVID-19 that retains activity against the omicron variant.
Key features of the study
This report provides in-depth analysis of the global monoclonal antibody therapeutics market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global monoclonal antibody therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study are Pfizer Inc., Novartis AG, Bayer AG, Sanofi, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Merck KGaA, GSK plc., AbbVie Inc., Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., AstraZeneca, AbCellera Biologics Inc., Molecular Depot LLC, DAIICHI SANKYO COMPANY, LIMITED., Abbott, Biogen, Thermo Fisher Scientific, Inc., Cell Signaling Technology, Inc, Intas Pharmaceuticals Ltd., Avantor Inc., UCB S.A., Merus N.V., GENEXTGENOMICS.COM, Biogenuix.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global monoclonal antibody therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibody therapeutics market.
Market Segmentation
Global Monoclonal Antibody Therapeutics Market, By Source
Human
Chimeric
Murine
Humanized
Global Monoclonal Antibody Therapeutics Market, By Application
Cancer
Autoimmune Disease
Hematological Disease
Infectious Disease
Others
Global Monoclonal Antibody Therapeutics Market, By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Monoclonal Antibody Therapeutics Market, By Region
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Pfizer Inc.
Novartis AG
Bayer AG
Sanofi
Hoffmann-La Roche Ltd.
Eli Lilly and Company
Merck KGaA
GSK plc
AbbVie Inc.
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals Inc.
AstraZeneca
AbCellera Biologics Inc.
Molecular Depot LLC
DAIICHI SANKYO COMPANY LIMITED
Abbott
Biogen
Thermo Fisher Scientific, Inc.
Cell Signaling Technology, Inc.
Intas Pharmaceuticals Ltd.
Avantor Inc.
UCB S.A.
Merus N.V.
GENEXTGENOMICS.COM
Biogenuix
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Source
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Highlights
Product Launch
Technological Advancements
PEST Analysis
Regulatory Scenario
Mergers and Acquisitions
4. Global Monoclonal Antibody Therapeutics Market, By Source, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Human
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chimeric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Murine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Humanized
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Monoclonal Antibody Therapeutics Market, By Application, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematological Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Monoclonal Antibody Therapeutics Market, By Distribution Channel, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segments Trends
Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Monoclonal Antibody Therapeutics Market, By Region, 2020 - 2032, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Regions, 2021-2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
